- Home
- GLMD vs BENF Comparison
GLMD vs BENF Comparison
Compare GLMD & BENF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLMD
- BENF
- Stock Information
- Founded
- GLMD 2000
- BENF 2003
- Country
- GLMD Israel
- BENF United States
- Employees
- GLMD N/A
- BENF N/A
- Industry
- GLMD Biotechnology: Pharmaceutical Preparations
- BENF Blank Checks
- Sector
- GLMD Health Care
- BENF Finance
- Exchange
- GLMD Nasdaq
- BENF Nasdaq
- Market Cap
- GLMD 3.0M
- BENF 2.3M
- IPO Year
- GLMD 2014
- BENF N/A
- Fundamental
- Price
- GLMD $1.57
- BENF $0.26
- Analyst Decision
- GLMD Hold
- BENF
- Analyst Count
- GLMD 1
- BENF 0
- Target Price
- GLMD N/A
- BENF N/A
- AVG Volume (30 Days)
- GLMD 105.5K
- BENF 110.3K
- Earning Date
- GLMD 05-29-2025
- BENF 02-13-2025
- Dividend Yield
- GLMD N/A
- BENF N/A
- EPS Growth
- GLMD N/A
- BENF N/A
- EPS
- GLMD N/A
- BENF N/A
- Revenue
- GLMD N/A
- BENF N/A
- Revenue This Year
- GLMD N/A
- BENF N/A
- Revenue Next Year
- GLMD N/A
- BENF N/A
- P/E Ratio
- GLMD N/A
- BENF N/A
- Revenue Growth
- GLMD N/A
- BENF N/A
- 52 Week Low
- GLMD $1.21
- BENF $0.26
- 52 Week High
- GLMD $23.80
- BENF $13.00
- Technical
- Relative Strength Index (RSI)
- GLMD 48.70
- BENF 36.54
- Support Level
- GLMD $1.30
- BENF $0.22
- Resistance Level
- GLMD $1.67
- BENF $0.28
- Average True Range (ATR)
- GLMD 0.14
- BENF 0.02
- MACD
- GLMD 0.06
- BENF 0.00
- Stochastic Oscillator
- GLMD 78.77
- BENF 40.93
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.
About BENF Beneficient
Beneficient is a technology-enabled financial services holding company that (together with its subsidiaries) provides simple, rapid, and cost-effective liquidity solutions to participants in the alternative asset industry through its end-to-end online platform, AltAccess. BCG's products and services are designed to meet the unmet needs of mid-to-high net-worth individual investors, small-to-midsize institutional investors, family offices, and fund general partners. Its bespoke liquidity solutions for otherwise illiquid alternative asset investments are delivered through proprietary technology and an innovative financing and trust structure. It has three reportable segments consisting of Ben Liquidity, Ben Custody and Customer ExAlt Trusts.